Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lippo Cikarang Tbk (LPCK) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance

Lippo Cikarang TbkTrade
Prodia Diagnostic Line TbkTrade

Price performance (Past 24H)

Key statistics

Lippo Cikarang Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Lippo Cikarang Tbk trades at Rp610 (market cap 3.16T, 347.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Lippo Cikarang Tbk is far larger — about 6.7× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 347.4K). Which is the better fit depends on your goals.

LPCKPRDL
Market Cap
3.16T470.58B
Volume
347.4K28.43M
Lot
3.47K284.34K
Turnover
211.93M7.8B
Average Price
610.04274.19
Value
211.93M7.8B
Indicative Equilibrium Price
610270
Indicative Equilibrium Volume
1022.1K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LPCK
View details
PRDL
View details

About Lippo Cikarang Tbk

PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.

Read more on LPCK

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL